ArticleClinicoEconomics and outcomes research : CEOR2021

Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome.

Sermsiri Sangroongruangsri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.